Cited by 322Allergic Rhinitis and SensitizationAsthma and respiratory diseasesSinusitis and nasal conditions

Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

Open access
Hellings, P. W., Klimek, L., Cingi, C., Agache, I., Akdis, C., Bachert, C., Bousquet, J., Demoly, P. +19 more·2017·Allergy

Abstract

This EAACI position paper aims at providing a state‐of‐the‐art overview on nonallergic rhinitis ( NAR ). A significant number of patients suffering from persistent rhinitis are defined as nonallergic noninfectious rhinitis ( NANIR ) patients, often denominated in short as having NAR . NAR is defined as a symptomatic inflammation of the nasal mucosa with the presence of a minimum of two nasal symptoms such as nasal obstruction, rhinorrhea, sneezing, and/or itchy nose, without clinical evidence of endonasal infection and without systemic signs of sensitization to inhalant allergens. Symptoms of NAR may have a wide range of severity and be either continuously present and/or induced by exposure to unspecific triggers, also called nasal hyperresponsiveness ( NHR ). NHR represents a clinical feature of both AR and NAR patients. NAR involves different subgroups: drug‐induced rhinitis, (nonallergic) occupational rhinitis, hormonal rhinitis (including pregnancy rhinitis), gustatory rhinitis, senile rhinitis, and idiopathic rhinitis ( IR ). NAR should be distinguished from those rhinitis patients with an allergic reaction confined to the nasal mucosa, also called “entopy” or local allergic rhinitis ( LAR ). We here provide an overview of the current consensus on phenotypes of NAR , recommendations for diagnosis, a treatment algorithm, and defining the unmet needs in this neglected area of research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/all.13200

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intranasal corticosteroids are first-line drugs for treating nonallergic rhinitis.

    “They are also the first-line drugs for treating NAR [135].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [135]

    The therapeutic algorithm (section 8; page unavailable) recommends tailoring treatment to the NAR phenotype, not using intranasal corticosteroids as first-line drugs for NAR generally. It says most randomized trials of local corticosteroids in NAR showed a lack of efficacy, although inflammatory phenotypes may benefit. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. Bousquet J, Bachert C, Canonica GW, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124:428-433.
  2. Hellings PW, Fokkens WJ, Akdis C, et al. Uncontrolled allergic rhini- tis and chronic rhinosinusitis: where do we stand today? Allergy 2013;68:1-7.
  3. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe-an underestimated disease. A GA 2 LEN study. Allergy. 2011;66:1216-1223.
  4. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378:2112-2122.
  5. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219-1232.
  6. Morais-Almeida M, Pite H, Pereira AM, et al. Prevalence and classifi- cation of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68:1150-1157.
  7. Orban N, Maughan E, Bleach N. Pregnancy-induced rhinitis. Rhinol- ogy. 2013;51:111-119.
  8. Hox V, Steelant B, Fokkens W, Nemery B, Hellings PW. Occupa- tional upper airway disease: how work affects the nose. Allergy. 2014;69:282-291.
  9. Jovancevic L, Georgalas C, Savovic S, Janjevic D. Gustatory rhinitis. Rhinology. 2010;48:7-10.
  10. Van Gerven L, Alpizar YA, Wouters MM, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2014;133:1332-1339.
  11. Bernstein JA. Allergic and mixed rhinitis: epidemiology and natural history. Allergy Asthma Proc. 2010;31:365-369.
  12. Hellings PW, Scadding G, Alobid I, et al. Executive summary of Euro- pean Task Force document on diagnostic tools in rhinology. Rhinol- ogy. 2012;50:339-352.
  13. Bousquet J, Fokkens W, Burney P, et al. Important research ques- tions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008;63:842-853.
  14. Chiang WC, Chen YM, Tan HKK, et al. Allergic rhinitis and non-aller- gic rhinitis in children in the tropics: prevalence and risk associations. Pediatr Pulmonol. 2012;47:1026-1033.
  15. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Preva- lence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61:693-698.
  16. Chawes BLK, Bønnelykke K, Kreiner-Møller E, Bisgaard H. Children with allergic and nonallergic rhinitis have a similar risk of asthma. J Allergy Clin Immunol. 2010;126:567-573.
  17. Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medica- mentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am. 2011;31:457-467.
  18. Malmberg H, Grahne B, Holopainen E, Binder E. Ipratropium (Atro- vent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol Allied Sci. 1983;8:273-276.
  19. Rodriguez K, Rubinstein E, Ferguson BJ. Clear anterior rhinorrhea in the population. Int Forum Allergy Rhinol. 2015;5:1063-1067.
  20. Hox V, Vanoirbeek JA, Alpizar YA, et al. Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonaller- gic airway hyperreactivity in mice. Am J Respir Crit Care Med. 2013;187:486-493.
  21. Karjalainen A, Martikainen R, Klaukka T, Saarinen K, Uitti J. Risk of asthma among Finnish patients with occupational rhinitis. Chest. 2003;123:283-288.
  22. Shusterman D. Nonallergic rhinitis: environmental determinants. Immunol Allergy Clin North Am. 2016;36:379-399.
  23. Kaliner MA. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organ J. 2009;2:98-101.
  24. Elleg ard E, Hellgren M, Tor en K, Karlsson G. The incidence of preg- nancy rhinitis. Gynecol Obstet Invest. 2000;49:98-101.
  25. Navarrete-Palacios E, Hudson R, Reyes-Guerrero G, Guevara- Guzm an R. Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle. Arch Otolaryngol Head Neck Surg. 2003;129:460-463.
  26. Hamano N, Terada N, Maesako K, et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells-the effects of sex hormones. Int Arch Allergy Immunol. 1998;115:220-227.
  27. Caparroz FA, Gregorio LL, Bongiovanni G, Izu SC, Kosugi EM. Rhini- tis and pregnancy: literature review. Braz J Otorhinolaryngol. 2016;82:105-111.
  28. Wei J, Gerlich J, Genuneit J, et al. Hormonal factors and incident asthma and allergic rhinitis during puberty in girls. Ann Allergy Asthma Immunol. 2015;115:21-27.
  29. Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy. 2010;40:381-384.
  30. Kirsche H, Klimek L. ASA-intolerance syndrome and persistent rhi- nosinusitis : differential diagnosis and treatment. HNO. 2015;63:357- 363.
  31. Subramanian H, Gupta K, Ali H. Roles of Mas-related G protein- coupled receptor X2 on mast cell-mediated host defense, pseudoal- lergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 2016;138:700-710.
  32. Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope. 2012;122:2615-2620.
  33. Jutel M, Papadopoulos NG, Gronlund H, et al. Recommendations for the allergy management in the primary care. Allergy. 2014;69:708- 718.
  34. Rond on C, Fern andez J, L opez S, et al. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol. 2009;124:1005-1011.
  35. Van Gerven L, Boeckxstaens G, Hellings P. Up-date on neuro- immune mechanisms involved in allergic and non-allergic rhinitis. Rhi- nology. 2012;50:227-235.
  36. Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. "Entopy": localized mucosal allergic disease in the absence of sys- temic responses for atopy. Clin Exp Allergy. 2003;33:1374-1379.
  37. Rond on C, Campo P, Galindo L, et al. Prevalence and clinical rele- vance of local allergic rhinitis. Allergy. 2012;67:1282-1288.
  38. Patel PN, Oyefara B, Aarstad R, Bahna SL. Rhinorrhea not respond- ing to nasal corticosteroids. Allergy Asthma Proc. 2007;28:735-738.
  39. Segboer CL, Holland CT, Reinartz SM, et al. Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy. 2013;68:1427-1434.
  40. Sanico AM, Philip G, Lai GK, Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in aller- gic rhinitis. J Appl Physiol. 1999;86:1202-1210.
  41. Gerth van Wijk R, Dieges PH. Nasal hyper-responsiveness to his- tamine, methacholine and phentolamine in patients with perennial non-allergic rhinitis and in patients with infectious rhinitis. Clin Oto- laryngol Allied Sci. 1991;16:133-137.
  42. Togias AG, Naclerio RM, Proud D, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985;76:1375-1381.
  43. Baroody FM. Nonallergic Rhinitis: mechanism of Action. Immunol Allergy Clin North Am. 2016;36:279-287.
  44. Baraniuk JN, Merck SJ. Neuroregulation of human nasal mucosa. Ann N Y Acad Sci. 2009;1170:604-609.
  45. Tan R, Corren J. Optimum treatment of rhinitis in the elderly. Drugs Aging. 1995;7:168-175.
  46. Saunders CJ, Christensen M, Finger TE, Tizzano M. Cholinergic neu- rotransmission links solitary chemosensory cells to nasal inflamma- tion. Proc Natl Acad Sci U S A. 2014;111:6075-6080.
  47. van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongo- ing quest. Allergy. 2005;60:1471-1481.
  48. Varricchio A, Capasso M, De Lucia A, et al. Intranasal flunisolide treatment in patients with non-allergic rhinitis. Int J Immunopathol Pharmacol. 2011;24:401-409.
  49. L€ ofkvist T, Svensson G. Treatment of vasomotor rhinitis with intra- nasal beclomethasone dipropionate (Becotide). Results from a dou- ble-blind cross-over study. Acta Allergol. 1976;31:227-238.
  50. Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot EE. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc. 2009;30:120-127.
  51. Lundblad L, Sipil€ a P, Farstad T, Drozdziewicz D. Mometasone furo- ate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121:505-509.
  52. Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec. 2001;63:76-81.
  53. Xu JJ, Sowerby L, Rotenberg BW. Aspirin desensitization for aspirin- exacerbated respiratory disease (Samter's Triad): a systematic review of the literature. Int Forum Allergy Rhinol. 2013;3:915-920.
  54. Fruth K, Pogorzelski B, Schmidtmann I, et al. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease. Allergy. 2013;68:659-665.
  55. Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am. 2009;29:669- 675.
  56. Klimek L, Dollner R, Pfaar O, Mullol J. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Curr Allergy Asthma Rep. 2014;14:441.
  57. Eriksson J, Ekerljung L, Sundblad B-M, et al. Cigarette smoking is associated with high prevalence of chronic rhinitis and low preva- lence of allergic rhinitis in men. Allergy. 2013;68:347-354.
  58. Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy. 1997;27:796-801.
  59. Ciabatti PG, D'Ascanio L. Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial. Acta Oto- laryngol. 2009;129:367-371.
  60. Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PGH, Blom HM, Fok- kens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idio- pathic rhinitis: a double-blind randomized application regimen study. Allergy. 2003;58:754-761.
  61. Fokkens W, Hellings P, Segboer C. Capsaicin for rhinitis. Curr Allergy Asthma Rep. 2016;16:60.
  62. Holland C, van Drunen C, Denyer J, et al. Inhibition of capsaicin-dri- ven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol. 2014;77:777-788.
  63. Orabi AA, Sen A, Timms MS, Morar P. Patient satisfaction survey of outpatient-based topical local anesthetic KTP laser inferior turbinec- tomy: a prospective study. Am J Rhinol. 2007;21:198-202.
  64. Robinson SR, Wormald PJ. Endoscopic vidian neurectomy. Am J Rhi- nol. 2006;20:197-202.

Cited by

Sorted by citations

Authors
Hellings, P. W., Klimek, L., Cingi, C., Agache, I., Akdis, C., Bachert, C., Bousquet, J., Demoly, P., Gevaert, P., Hox, V., Hupin, C., Kalogjera, L., Manole, F., Mösges, R., Mullol, J., Muluk, N. B., Muraro, A., Papadopoulos, N., Pawankar, R., Rondon, C., Rudenko, M., Seys, S. F., Toskala, E., Van Gerven, L., Zhang, L., Zhang, N., & Fokkens, W. J.
Affiliations
  • Universitair Ziekenhuis Leuven (BE)
  • Zentrum für Rhinologie und Allergologie (DE)
  • Eskişehir Osmangazi University (TR)
  • Transilvania University of Brașov (RO)
  • Swiss Institute of Allergy and Asthma Research Christine Kuhne-Center for Allergy Research and Education University of Zurich Davos Switzerland
  • Ghent University Hospital (BE)
  • Centre Hospitalier Universitaire de Montpellier (FR)
  • Cliniques Universitaires Saint-Luc (BE)
  • Sisters of Charity Hospital (HR)
  • University of Oradea (RO)
  • Institute of Medical Statistics, Informatics, and Epidemiology Medical Faculty University of Köln Cologne Germany
  • Hospital Clínic de Barcelona (ES)
  • Kırıkkale University (TR)
  • University of Padua (IT)
  • National and Kapodistrian University of Athens (GR)
  • Nippon Medical School (JP)
  • Allergy Service Carlos Haya Hospital Malaga Spain
  • London Allergyology and Immunology Center London UK
  • KU Leuven (BE)
  • Department of Otorhinolaryngology-Head and Neck Surgery Temple University Philadelphia USA
  • Clinical division of Otorhinolaryngology Head & Neck Surgery University Hospitals Leuven Leuven Belgium
  • Beijing Tongren Hospital (CN)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Hellings, P. W.
Venue
Allergy
Publisher
Wiley
Published
2017-06-02
Volume
72
Issue
11
Pages
1657-1665
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W4245191120
Cited by
322
References
8
Citations by year
2026: 23 · 2025: 36 · 2024: 34 · 2023: 37 · 2022: 49 · 2021: 41 · 2020: 44 · 2019: 27 · 2018: 23 · 2017: 6
FWCI
22.21
Type
journal article
Language
en
Open access
Locations
  • Allergy (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
  • Lirias (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
Keywords
non-allergic rhinitis, nasal hyperreactivity, drug-induced rhinitis, occupational rhinitis, vasomotor rhinitis, local allergic rhinitis, nasal mucosa inflammation, diagnosis, treatment algorithm, phenotypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review